Dextran-70 to modulate inflammatory response after cardiopulmonary bypass: Potential for a novel approach?

4Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Potential deleterious effects of cardiopulmonary bypass (CPB) and cardioplegic cardiac arrest are known to influence outcome. The inflammatory response after CPB may have unfavourable effects especially in high-risk patients, for example, the very elderly. Thus, to blunt the release of pro-inflammatory mediators seems to be a promising approach. So far, numerous attempts at immune modulation have been performed. However, the management of cardiac surgery patients needs further improvement. In this context, Gombocz and colleagues investigated the potential anti-inflammatory effect of dextran-70. Their results suggest that compared to gelatine, dextran-70 reduces the inflammatory response in patients after CPB. © 2007 BioMed Central Ltd.

Cite

CITATION STYLE

APA

Schuerholz, T., & Marx, G. (2007, September 5). Dextran-70 to modulate inflammatory response after cardiopulmonary bypass: Potential for a novel approach? Critical Care. https://doi.org/10.1186/cc6103

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free